Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Piramal | Healthcare

Pharma Solutions is the contract development and manufacturing (CDMO) division of Piramal | Healthcare, a part of the Piramal Enterprise. We are one of the largest custom manufacturing companies in the world that provides flexibility and scalability of operations. We have created a vast network of contract development and manufacturing facilities located in North America, Europe and Asia that offers a multitude of services that cover the entire drug-cycle, from development and commercial manufacturing to off-patent supplies of Active Pharmaceutical Ingredients (APIs) and formulations. Our network enables us to deliver benefits by strategically placing projects to take advantage of low costs, local supply chains and specific customer/ market requirements. This division features among the top 10 contract drug manufacturers in the world.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Piramal | Healthcare
247 Business Park, A - Wing, 6th Floor, LBS Marg, Vikhroli (West), Mumbai, Maharashtra, 400083, India
022-30956893
Contact Piramal | Healthcare
Website

 Latest Content from PMHub 

How to get your sales force to use digital tools

White Papers and Resources | April 28, 2017 | Anthill Agency

You have the perfect digital strategy. You provide the most advanced digital sales tools. You power it with amazing content. And then discover that customer-facing staff aren’t using it. Wait....

New analysis shows emergency hospital admissions for people with Multiple Sclerosis continue to rise

Press Releases | April 26, 2017 | Wilmington Healthcare

Updated data published by Wilmington Healthcare and the MS Trust highlights need for more preventative care for MS patients

The right way to capture customer data

White Papers and Resources | April 25, 2017 | Anthill Agency

Digital communication should be a two-way process with information flowing backwards and forwards between you and healthcare professionals. That digital technology enables HCPs to give feedback is a big part...

Can you access your own content?

White Papers and Resources | April 24, 2017 | Anthill Agency

The rapid development of multichannel communication opens new opportunities to provide high-value experiences for healthcare professionals and gives you more places than ever to tell your product story. But unless...

How will capitated budgets affect NHS spending?

White Papers and Resources | April 21, 2017 | Wilmington Healthcare

Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess the implications of a single budget covering all the physical, mental and social care needs of patients in an STP

Lucid Group Achieve UK’s Highest Award for Business Success

Press Releases | April 21, 2017 | Lucid Group Communications Limited

Lucid Group have been chosen to receive a Queen’s Award for Enterprise in International Trade. This award is widely regarded as the UK’s highest accolade for business success and they...

Blossoming creative services at Porterhouse Medical

Press Releases | April 18, 2017 | Porterhouse Medical Group

The team at Porterhouse Medical is delighted to announce the promotion of Richard Oakham to the role of Creative Services Manager. Since joining our agency last September, Richard has made a very positive...

A safe place to talk about Crohn’s

White Papers and Resources | April 12, 2017 | Inizio

Published in eyeforpharma April 2017 by Mariel Metcalfe

Culture cannot be global: doing business outside your comfort zone

White Papers and Resources | April 12, 2017 | Blue Latitude Health

Dorottya Okros of Blue Latitude Health talks through the common communication and negotiation pitfalls of working with Eastern Europe and the CIS for British presenters.

Patient Assistance Programme Evaluation for Cardiovascular Conditions

White Papers and Resources | April 11, 2017 | Inizio

Our client had launched a self-injection treatment for cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in the use and uptake of this product.Read the case...